Skip to main content

PAPEL DE LA TOPOISOMERASA II EN LA ORGANIZACION, EXPRESION Y ESTABILIDAD DEL GENOMA: IMPLICACIONES PATOLOGICAS Y OPORTUNIDADES TERAPEUTICAS

SAF2017-89619-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 15
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Genome-wide prediction of topoisomerase IIβ binding by architectural factors and chromatin accessibility.

  • Martínez-García, Pedro Manuel
  • García-Torres, Miguel
  • Divina, Federico
  • Terrón-Bautista, José
  • Delgado-Sainz, Irene
  • Gómez-Vela, Francisco
  • Cortes-Ledesma, Felipe
DNA topoisomerase II-β (TOP2B) is fundamental to remove topological problems linked to DNA metabolism and 3D chromatin architecture, but its cut-and-reseal catalytic mechanism can accidentally cause DNA double-strand breaks (DSBs) that can seriously compromise genome integrity. Understanding the factors that determine the genome-wide distribution of TOP2B is therefore not only essential for a complete knowledge of genome dynamics and organization, but also for the implications of TOP2-induced DSBs in the origin of oncogenic translocations and other types of chromosomal rearrangements. Here, we conduct a machine-learning approach for the prediction of TOP2B binding using publicly available sequencing data. We achieve highly accurate predictions, with accessible chromatin and architectural factors being the most informative features. Strikingly, TOP2B is sufficiently explained by only three features: DNase I hypersensitivity, CTCF and cohesin binding, for which genome-wide data are widely available. Based on this, we develop a predictive model for TOP2B genome-wide binding that can be used across cell lines and species, and generate virtual probability tracks that accurately mirror experimental ChIP-seq data. Our results deepen our knowledge on how the accessibility and 3D organization of chromatin determine TOP2B function, and constitute a proof of principle regarding the in silico prediction of sequence-independent chromatin-binding factors.
Repisalud
Publication Artículo científico (JournalArticle)

"An End to a Means": How DNA-End Structure Shapes the Double-Strand Break Repair Process.

  • Serrano-Benítez, Almudena
  • Cortes-Ledesma, Felipe
  • Ruiz, Jose F
Endogenously-arising DNA double-strand breaks (DSBs) rarely harbor canonical 5'-phosphate, 3'-hydroxyl moieties at the ends, which are, regardless of the pathway used, ultimately required for their repair. Cells are therefore endowed with a wide variety of enzymes that can deal with these chemical and structural variations and guarantee the formation of ligatable termini. An important distinction is whether the ends are directly "unblocked" by specific enzymatic activities without affecting the integrity of the DNA molecule and its sequence, or whether they are "processed" by unspecific nucleases that remove nucleotides from the termini. DNA end structure and configuration, therefore, shape the repair process, its requirements, and, importantly, its final outcome. Thus, the molecular mechanisms that coordinate and integrate the cellular response to blocked DSBs, although still largely unexplored, can be particularly relevant for maintaining genome integrity and avoiding malignant transformation and cancer.
Repisalud
Publication Artículo científico (JournalArticle)

A Genetic Map of the Response to DNA Damage in Human Cells.

  • Olivieri, Michele
  • Cho, Tiffany
  • Álvarez-Quilón, Alejandro
  • Li, Kejiao
  • Schellenberg, Matthew J
  • Zimmermann, Michal
  • Hustedt, Nicole
  • Rossi, Silvia Emma
  • Adam, Salomé
  • Melo, Henrique
  • Heijink, Anne Margriet
  • Sastre-Moreno, Guillermo
  • Moatti, Nathalie
  • Szilard, Rachel K
  • McEwan, Andrea
  • Ling, Alexanda K
  • Serrano-Benitez, Almudena
  • Ubhi, Tajinder
  • Feng, Sumin
  • Pawling, Judy
  • Delgado-Sainz, Irene
  • Ferguson, Michael W
  • Dennis, James W
  • Brown, Grant W
  • Cortes-Ledesma, Felipe
  • Williams, R Scott
  • Martin, Alberto
  • Xu, Dongyi
  • Durocher, Daniel
  • Olivieri, Michele
  • Cho, Tiffany
  • Álvarez-Quilón, Alejandro
  • Li, Kejiao
  • Schellenberg, Matthew J
  • Zimmermann, Michal
  • Hustedt, Nicole
  • Rossi, Silvia Emma
  • Adam, Salomé
  • Melo, Henrique
  • Heijink, Anne Margriet
  • Sastre-Moreno, Guillermo
  • Moatti, Nathalie
  • Szilard, Rachel K
  • McEwan, Andrea
  • Ling, Alexanda K
  • Serrano-Benitez, Almudena
  • Ubhi, Tajinder
  • Feng, Sumin
  • Pawling, Judy
  • Delgado-Sainz, Irene
  • Ferguson, Michael W
  • Dennis, James W
  • Brown, Grant W
  • Williams, R Scott
  • Martin, Alberto
  • Xu, Dongyi
  • Durocher, Daniel
The response to DNA damage is critical for cellular homeostasis, tumor suppression, immunity, and gametogenesis. In order to provide an unbiased and global view of the DNA damage response in human cells, we undertook 31 CRISPR-Cas9 screens against 27 genotoxic agents in the retinal pigment epithelium-1 (RPE1) cell line. These screens identified 890 genes whose loss causes either sensitivity or resistance to DNA-damaging agents. Mining this dataset, we discovered that ERCC6L2 (which is mutated in a bone-marrow failure syndrome) codes for a canonical non-homologous end-joining pathway factor, that the RNA polymerase II component ELOF1 modulates the response to transcription-blocking agents, and that the cytotoxicity of the G-quadruplex ligand pyridostatin involves trapping topoisomerase II on DNA. This map of the DNA damage response provides a rich resource to study this fundamental cellular system and has implications for the development and use of genotoxic agents in cancer therapy.
Repisalud
Publication Artículo científico (JournalArticle)

Topoisomerase IIα represses transcription by enforcing promoter-proximal pausing.

  • Herrero-Ruiz, Andrés
  • Martínez-García, Pedro Manuel
  • Terrón-Bautista, José
  • Millán-Zambrano, Gonzalo
  • Lieberman, Jenna Ariel
  • Jimeno-González, Silvia
  • Cortes-Ledesma, Felipe
Accumulation of topological stress in the form of DNA supercoiling is inherent to the advance of RNA polymerase II (Pol II) and needs to be resolved by DNA topoisomerases to sustain productive transcriptional elongation. Topoisomerases are therefore considered positive facilitators of transcription. Here, we show that, in contrast to this general assumption, human topoisomerase IIα (TOP2A) activity at promoters represses transcription of immediate early genes such as c-FOS, maintaining them under basal repressed conditions. Thus, TOP2A inhibition creates a particular topological context that results in rapid release from promoter-proximal pausing and transcriptional upregulation, which mimics the typical bursting behavior of these genes in response to physiological stimulus. We therefore describe the control of promoter-proximal pausing by TOP2A as a layer for the regulation of gene expression, which can act as a molecular switch to rapidly activate transcription, possibly by regulating the accumulation of DNA supercoiling at promoter regions.
RIO. Repositorio Institucional Olavide
Publication Contribución de congreso (ConferenceOutput)

Regulation of transcription initiation by topoisomerase II β

  • Jimeno González, Silvia
  • Herrero Ruiz, Andrés
  • Martínez García, Pedro Manuel|||0000-0002-2119-2465
  • Cortés Ledesma, Felipe
En este estudio, analizamos cómo la topoisomerasa II beta (TOP2B) regula la iniciación de la transcripción en células humanas. Al inactivar esta enzima con merbarona, observamos que los genes de respuesta inmediata aumentan su expresión de forma drástica y breve. Estos genes específicos se caracterizan por tener promotores de cromatina abierta y polimerasas pausadas. A través de experimentos de unión a la cromatina, determinamos que la inhibición de TOP2B provoca un incremento en la iniciación que contrarresta la barrera de pausa proximal al promotor. Finalmente, proponemos un modelo en el que la TOP2B elimina el superenrollamiento negativo para reprimir la iniciación basal en genes con alta pausa proximal.
RIO. Repositorio Institucional Olavide
Publication Contribución de congreso (ConferenceOutput)

TOP2 and YY1 occupancy predict promoter proximal pausing genome wide

  • Martínez García, Pedro Manuel|||0000-0002-2119-2465
  • Cortés Ledesma, Felipe
En este trabajo, evaluamos la capacidad de diversos factores genéticos y epigenéticos para predecir la pausa proximal del promotor (PPP), un proceso fundamental en la regulación de la expresión génica en eucariotas superiores. A través de nuestro análisis, identificamos que la ADN Topoisomerasa II (TOP2) y la proteína estructural YY1 presentan el mayor poder predictivo positivo del estado de pausa en los promotores. Asimismo, demostramos que la proteína CTCF actúa como un predictor negativo de la pausa, sugiriendo que su asociación con este proceso propuesta en la literatura se debe a su co-localización con TOP2B y YY1. Nuestro estudio sugiere que tanto la topología del ADN como los bucles potenciador-promotor mediados por YY1 son elementos clave en el control de la PPP.
RIO. Repositorio Institucional Olavide
Publication Contribución de congreso (ConferenceOutput)

Genome wide profiling of Topoisomerase 2 activity

  • Terrón Bautista, José
  • Gómez Marín, Carlos
  • Martínez García, Pedro Manuel|||0000-0002-2119-2465
  • Cortés Ledesma, Felipe
En este trabajo estudiamos la actividad de la topoisomerasa II beta (TOP2B) mediante un mapeo genómico completo de sus intermediarios catalíticos para comprender su papel en la estabilidad y la arquitectura del genoma. Aunque estas enzimas sin esenciales para resolver problemas topológicos en el ADN, pueden generar roturas de doble cadena potencialmente dañinas si el equilibrio de su reacción se altera. Mediante este estudio, identificamos sistemáticamente los sitios en los que opera TOP2B para localizar "puntos calientes" de fragilidad genómica, relacionándolos con la regulación de genes de respuesta temprana y la configuración 3D del genoma en asociación con reguladores de la arquitectura como CTCF.
RIO. Repositorio Institucional Olavide
Publication Contribución de congreso (ConferenceOutput)

Genome wide association of TOP2B and CTCF binding with promoter- proximal transcriptional pausing

  • Martínez García, Pedro Manuel|||0000-0002-2119-2465
  • Gómez Marín, Carlos
  • Herrero Ruiz, Andrés
  • Jimeno González, Silvia
  • Cortés-Ledesma, Felipe
Este estudio investiga cómo la interacción entre la topoisomerasa TOP2B y el factor de arquitectura cromosómica CTCF regula la pausa de la ARN polimerasa II en los promotores génicos. Analizando datos de secuenciación masiva mediante métodos de aprendizaje automático supervisado, nuestro trabajo sugiere que la acción conjunta de la topología del ADN y la organización de la cromatina controla la transición hacia una elongación transcripcional productiva.
RIO. Repositorio Institucional Olavide
Publication Contribución de congreso (ConferenceOutput)

Analysis of Relevance and Redundance on Topoisomerase 2b (TOP2B) Binding Sites: A Feature Selection Approach

  • Martínez García, Pedro Manuel|||0000-0002-2119-2465
  • García Torres, Miguel|||0000-0002-6867-7080
  • Divina, Federico|||0000-0002-0964-9506
  • Gómez-Vela, Francisco Antonio|||0000-0001-7376-5790
  • Felipe Cortés-Ledesma
En este estudio empleamos técnicas de aprendizaje automático y selección de atributos para identificar elementos genómicos que determinan la unión de la proteína Topoisomerasa 2b (TOP2B) al genoma. En concreto, hacemos uso de datos de accesibilidad del ADN, arquitectura de la cromatina, marcas epigenéticas, expresión, entre otros. Nuestros modelos predicen los sitios de unión de TOP2B con un 94% de precisión basándose exclusivamente en tres elementos: la accesibilidad del ADN (DNase-seq) y la presencia de proteínas del complejo de cohesina (RAD21 y STAG2). Estos resultados sugieren que la localización de la TOP2B está definida principalmente por la estructura tridimensional y la apertura de la cromatina en las anclas de los bucles de ADN.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

“An end to a means”: How DNA-end structure shapes the double-strand break repair process

  • Serrano-Benítez, Almudena
  • Cortés-Ledesma, Felipe
  • Ruiz, José F.
Endogenously-arising DNA double-strand breaks (DSBs) rarely harbor canonical 5′-phosphate, 3′-hydroxyl moieties at the ends, which are, regardless of the pathway used, ultimately required for their repair. Cells are therefore endowed with a wide variety of enzymes that can deal with these chemical and structural variations and guarantee the formation of ligatable termini. An important distinction is whether the ends are directly “unblocked” by specific enzymatic activities without affecting the integrity of the DNA molecule and its sequence, or whether they are “processed” by unspecific nucleases that remove nucleotides from the termini. DNA end structure and configuration, therefore, shape the repair process, its requirements, and, importantly, its final outcome. Thus, the molecular mechanisms that coordinate and integrate the cellular response to blocked DSBs, although still largely unexplored, can be particularly relevant for maintaining genome integrity and avoiding malignant transformation and cancer., Work in the FC-L laboratory was funded with grants from the Spanish and Andalusian Government (SAF2017-89619-R, CVI-7948, European Regional Development Fund), and the European Research Council (ERC-CoG-2014-647359); and with an individual fellowship for AS-B (Beca Predoctoral AEFAT, Asociación Española Familia Ataxia Telangiectasia). CABIMER was supported by the Andalusian Government., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Endogenous topoisomerase II-mediated DNA breaks drive thymic cancer predisposition linked to ATM deficiency

  • Álvarez-Quilón, Alejandro
  • Terrón-Bautista, José
  • Delgado, Irene
  • Serrano-Benítez, Almudena
  • Romero-Granados, Rocío
  • Martínez-García, Pedro Manuel
  • Jimeno-González, Silvia
  • Bernal-Lozano, Cristina
  • Quintero, Cristina
  • García-Quintanilla, Lourdes
  • Cortés-Ledesma, Felipe
The ATM kinase is a master regulator of the DNA damage response to double-strand breaks (DSBs) and a well-established tumour suppressor whose loss is the cause of the neurodegenerative and cancer-prone syndrome Ataxia-Telangiectasia (A-T). A-T patients and Atm−/− mouse models are particularly predisposed to develop lymphoid cancers derived from deficient repair of RAG-induced DSBs during V(D)J recombination. Here, we unexpectedly find that specifically disturbing the repair of DSBs produced by DNA topoisomerase II (TOP2) by genetically removing the highly specialised repair enzyme TDP2 increases the incidence of thymic tumours in Atm−/− mice. Furthermore, we find that TOP2 strongly colocalizes with RAG, both genome-wide and at V(D)J recombination sites, resulting in an increased endogenous chromosomal fragility of these regions. Thus, our findings demonstrate a strong causal relationship between endogenous TOP2-induced DSBs and cancer development, confirming these lesions as major drivers of ATM-deficient lymphoid malignancies, and potentially other conditions and cancer types., This work has been funded with grants from the Spanish and Andalusian Government (SAF2010-21017, SAF2013-47343-P, SAF2014-55532-R, SAF2017-89619-R, CVI-7948, European Regional Development Fund), and the European Research Council (ERC-CoG-2014-647359); and with individual fellowships for AAQ (Formación Personal Investigador, BES-2011-047351, Ministerio de Ciencia e Innovación), JTB (Formación Profesorado Universitario, FPU15/03656, Ministerio de Educación, Cultura y Deporte) and ASB (Beca Predoctoral AEFAT, Asociación Española Familia Ataxia Telangiectasia). CABIMER is supported by the Andalusian Government., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Ubiquitin stimulated reversal of topoisomerase 2 DNA-protein crosslinks by TDP2

  • Schellenberg, Matthew J.
  • Appel, C. Denise
  • Riccio, Amanda A.
  • Butler, Logan R.
  • Krahn, Juno M.
  • Lieberman, Jenna Ariel
  • Cortés-Ledesma, Felipe
  • Williams, R. Scott
Tyrosyl-DNA phosphodiesterase 2 (TDP2) reverses Topoisomerase 2 DNA–protein crosslinks (TOP2-DPCs) in a direct-reversal pathway licensed by ZATTZNF451 SUMO2 E3 ligase and SUMOylation of TOP2. TDP2 also binds ubiquitin (Ub), but how Ub regulates TDP2 functions is unknown. Here, we show that TDP2 co-purifies with K63 and K27 poly-Ubiquitinated cellular proteins independently of, and separately from SUMOylated TOP2 complexes. Poly-ubiquitin chains of ≥ Ub3 stimulate TDP2 catalytic activity in nuclear extracts and enhance TDP2 binding of DNA–protein crosslinks in vitro. X-ray crystal structures and small-angle X-ray scattering analysis of TDP2-Ub complexes reveal that the TDP2 UBA domain binds K63-Ub3 in a 1:1 stoichiometric complex that relieves a UBA-regulated autoinhibitory state of TDP2. Our data indicates that that poly-Ub regulates TDP2-catalyzed TOP2-DPC removal, and TDP2 single nucleotide polymorphisms can disrupt the TDP2-Ubiquitin interface., Intramural research program of the US National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS) [1Z01ES102765 to R.S.W.]; Work in the F.C.L. lab is supported by Ministerio de Economía y Competitividad, Gobierno de España [SAF2017-89619-R, European Regional Development Fund]; European Research Council [ERC-CoG-2014-647359]; University of Seville Predoctoral Studentship [PIF-2011 to J.A.L.]; M.J.S. is supported by Mayo Clinic start-up funds and the Center for Biomedical Discovery new investigator funds; Data were collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory; Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; SAXS data were collected at the Advanced Light Source (ALS), a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the Department of Energy, Office of Basic Energy Sciences, through the Integrated Diffraction Analysis Technologies (IDAT) program, supported by DOE Office of Biological and Environmental Research. Additional support comes from the National Institute of Health project ALS-ENABLE [P30 GM124169]; High-End Instrumentation Grant [S10OD018483]. Funding for open access charge: US government, Intramural NIH., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

A genetic map of the response to DNA damage in human cells

  • Olivieri, Michele
  • Cho, Tiffany
  • Álvarez-Quilón, Alejandro
  • Li, Kejiao
  • Schellenberg, Matthew J.
  • Zimmermann, Michal
  • Hustedt, Nicole
  • Rossi, Silvia Emma
  • Adam, Salomé
  • Melo, Henrique
  • Heijink, Anne Margriet
  • Sastre-Moreno, Guillermo
  • Moatti, Nathalie
  • Szilard, Rachel K.
  • McEwan, Andrea
  • Ling, Alexandra K.
  • Serrano-Benítez, Almudena
  • Ubhi, Tajinder
  • Delgado, Irene
  • Ferguson, Michael W.
  • Brown, Grant W.
  • Cortés-Ledesma, Felipe
  • Williams, R. Scott
  • Martin, Alberto
  • Xu, Dongyi
  • Durocher, Daniel
Versión postprint próximamente disponible en: http://hdl.handle.net/10261/228202, The response to DNA damage is critical for cellular homeostasis, tumor suppression, immunity and gametogenesis. In order to provide an unbiased and global view of the DNA damage response in human cells, we undertook 28 CRISPR/Cas9 screens against 25 genotoxic agents in the retinal pigment epithelium-1 (RPE1) cell line. These screens identified 840 genes whose loss causes either sensitivity or resistance to DNA damaging agents. Mining this dataset, we uncovered that ERCC6L2, which is mutated in a bone-marrow failure syndrome, codes for a canonical non-homologous end-joining pathway factor; that the RNA polymerase II component ELOF1 modulates the response to transcription-blocking agents and that the cytotoxicity of the G-quadruplex ligand pyridostatin involves trapping topoisomerase II on DNA. This map of the DNA damage response provides a rich resource to study this fundamental cellular system and has implications for the development and use of genotoxic agents in cancer therapy., AAQ, GSM and AMH are recipients of long-term EMBO fellowships (ALTF 910-2017, 795-2017 under a CC-BY-NC-ND 4.0 International license. not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available bioRxiv preprint doi: https://doi.org/10.1101/845446; this version posted November 18, 2019. The copyright holder for this preprint (which was 27 and 124-2019, respectively), NH was supported by a Human Frontier Science Program long-term Fellowship, SER is supported by a fellowship from AIRC and SA was a Banting post-doctoral fellow. ASB was supported by a PhD Studentship from AEFAT (Asociación Española Familia Ataxia Telangiectasia) and an EMBO short-term fellowship for a visit to the DD laboratory. The ICRF187 screen in FCL laboratory was funded by grants from the Spanish Government (SAF2017- 89619-R, European Regional Development Fund) and the European Research Council (ERC-CoG2014-647359). Work in the RSW laboratory was supported in part by the US National Institute of Health Intramural Program, US National Institute of Environmental Health Sciences (NIEHS, 1Z01ES102765). DD is a Canada Research Chair (Tier I) and the work was supported from grants from the CIHR (FDN143343 to DD; FRN 123518, PJT-156330 to AM) Canadian Cancer Society grant 705644 (to DD) with additional support to DD from the Krembil Foundation., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Topoisomerase IIα represses transcription by enforcing promoter-proximal pausing

  • Herrero-Ruiz, Andrés
  • Martínez-García, Pedro Manuel
  • Terrón-Bautista, José
  • Millán-Zambrano, Gonzalo
  • Lieberman, Jenna Ariel
  • Jimeno-González, Silvia
  • Cortés-Ledesma, Felipe
Accumulation of topological stress in the form of DNA supercoiling is inherent to the advance of RNA polymerase II (Pol II) and needs to be resolved by DNA topoisomerases to sustain productive transcriptional elongation. Topoisomerases are therefore considered positive facilitators of transcription. Here, we show that, in contrast to this general assumption, human topoisomerase IIα (TOP2A) activity at promoters represses transcription of immediate early genes such as c-FOS, maintaining them under basal repressed conditions. Thus, TOP2A inhibition creates a particular topological context that results in rapid release from promoter-proximal pausing and transcriptional upregulation, which mimics the typical bursting behavior of these genes in response to physiological stimulus. We therefore describe the control of promoter-proximal pausing by TOP2A as a layer for the regulation of gene expression, which can act as a molecular switch to rapidly activate transcription, possibly by regulating the accumulation of DNA supercoiling at promoter regions., This work was funded with grants from the Spanish and Andalusian governments (SAF2017-89619-R, CVI-7948, and European Regional Development Fund) and the European Research Council (ERC-CoG-2014-647359), and with individual fellowships for A.H.-R. (Contratos para la Formación de Doctores, BES-2015-071672, and Ministerio de Economía y Competitividad); S.J.-G. (Ramón y Cajal, RYC-2015-17246, and Ministerio de Economía y Competitividad); J.T.-B. (Formación Profesorado Universitario, FPU15/03656, and Ministerio de Educación, Cultura y Deporte); and G.M.-Z. (AECC Postdoctoral Fellowships). CABIMER is supported by the Andalusian Government.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

TOP2B modulates DNA supercoiling and chromatin contacts during transcriptional induction

  • Terrón-Bautista, José
  • Bejarano-Franco, Marina
  • Del Mar Martínez-Sánchez, María
  • López-Hernández, Laura
  • Díaz-Maldonado, Héctor
  • Santiago-Gómez, Angélica
  • Kidane, Sara
  • Jaguva Vasudevan, Ananda Ayyappan
  • García-Domínguez, Mario
  • Williams, R Scott
  • Aguilera, Andrés
  • Millán-Zambrano, Gonzalo
  • Cortés-Ledesma, Felipe
Human type-II topoisomerases, TOP2A and TOP2B, resolve transcription-associated DNA supercoiling, thereby influencing gene expression programs, and have been recently linked to three-dimensional genome architecture through yet poorly understood mechanisms. Here, we investigate the regulatory roles of TOP2 paralogs using estrogen signaling, which triggers an acute transcriptional induction that involves extensive rewiring of genome organization, as a model system. Unexpectedly, we find that estrogen treatment strongly inhibits TOP2B catalytic activity-although not its binding-specifically at estrogen-responsive enhancers and promoters. This inhibition results in an accumulation of negative DNA supercoiling and promotes the formation of regulatory chromatin contacts. Estrogen-mediated inhibition of TOP2B activity depends on estrogen receptor α, a noncatalytic function of TOP2A, and, most importantly, the action of zinc finger protein associated with tyrosyl-DNA phosphodiesterase 2 and TOP2, an atypical small ubiquitin-like modifier ligase that directly inhibits TOP2 activity. This mechanism of transcriptional control, involving the fine-tuning of DNA supercoiling levels, highlights the role of DNA topoisomerases as central regulators of genome dynamics., This work is funded by the MCIN/AEI/10.13039/501100011033 and ERDF “A way of making Europe” grant SAF2017-89619-R (F.C.-L.); the MCIN/AEI/10.13039/501100011033 and ERDF “A way of making Europe” grant PID2020-119570RB-I00 (F.C.-L.); the MCIN/AEI/10.13039/501100011033 and ERDF “A way of making Europe” grant PID2023-153302OB-I00 (F.C.-L.); the European Research Council ERC consolidator grant ERC-CoG-2014-647359 (F.C.-L.); the “la Caixa” Foundation Health Research grant HR24-00980 (F.C.-L.); the MCIN/AEI/10.13039/501100011033 and ERDF “A way of making Europe” grant PID2021-127432 N (G.M.-Z.); the MCIN/AEI/10.13039/501100011033 and ERDF “A way of making Europe” grant RC-CNS2022-135600 (G.M.-Z.); the Asociación Española Contra el Cáncer grant POSTD18021MILL (G.M.-Z.); the La Caixa Foundation Fellowship ID 100010434 (G.M.-Z.); the European Union Horizon 2020 Marie Skłodowska-Curie grant LCF/BQ/PR21/11840007 (G.M.-Z.); the Consejería de Transformación Económica, Industria, Conocimiento y Universidades, Junta de Andalucía, Emergia 2021grant EMC21_00222 (G.M.-Z.); the MCIN/AEI/10.13039/501100011033 and ERDF “A way of making Europe” grant PID2019-104270GB-I00/BMC (A.A.); the European Research Council ERC Advanced Grant ERC-AdG-2014-669898 (A.A.); the US National Institutes of Health intramural program, National Institute of Environmental Health Sciences (NIEHS), grant 1Z01ES102765 (R.S.W.); the Ministerio de Educación, Cultura y Deporte Predoctoral Fellowship FPU15/03656 (J.T.-B.); the Agencia Estatal de Investigación Predoctoral Fellowship SEV-2015-0510-19-1, PRE2019-090967 (M.d.M.M.-S.); and the Spanish National Cancer Center (CNIO), CNIO Friends Postdoctoral Contract (H.D.-M.)., Peer reviewed